Iqvia Holdings Inc
General ticker "IQV" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $36.4B
Iqvia Holdings Inc follows the US Stock Market performance with the rate: 8.3%.
Estimated limits based on current volatility of 1.7%: low 191.76$, high 198.54$
Factors to consider:
- Company included in S&P500 list
- North and South America accounted for 50.4% of revenue in the fiscal year ended 2023-12-31
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [207.60$, 294.05$]
- 2024-12-30 to 2025-12-30 estimated range: [259.71$, 353.32$]
Financial Metrics affecting the IQV estimates:
- Positive: Non-GAAP EPS, $ of 10.21 > 2.29
- Positive: Inventory ratio change, % of -0.47 <= 0
- Positive: 9.05 < Operating profit margin, % of 13.19
- Negative: Industry inventory ratio change (median), % of 1.54 > 0.49
- Negative: Industry operating cash flow per share per price (median), % of 0.50 <= 3.85
- Negative: Industry earnings per price (median), % of -3.50 <= 1.31
Short-term IQV quotes
Long-term IQV plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $13,874.00MM | $14,410.00MM | $14,984.00MM |
| Operating Expenses | $12,481.00MM | $12,611.00MM | $13,007.00MM |
| Operating Income | $1,393.00MM | $1,799.00MM | $1,977.00MM |
| Non-Operating Income | $-265.00MM | $-436.00MM | $-518.00MM |
| Interest Expense | $375.00MM | $416.00MM | $672.00MM |
| Income(Loss) | $1,128.00MM | $1,363.00MM | $1,459.00MM |
| Taxes | $163.00MM | $260.00MM | $101.00MM |
| Other Income(Loss) | $1.00MM | $-12.00MM | $0.00MM |
| Profit(Loss) | $966.00MM | $1,091.00MM | $1,358.00MM |
| Stockholders Equity | $6,042.00MM | $5,765.00MM | $6,112.00MM |
| Inventory | $156.00MM | $151.00MM | $0.00MM |
| Assets | $24,689.00MM | $25,337.00MM | $26,681.00MM |
| Operating Cash Flow | $2,942.00MM | $2,260.00MM | $2,149.00MM |
| Capital expenditure | $640.00MM | $674.00MM | $649.00MM |
| Investing Cash Flow | $-2,103.00MM | $-2,006.00MM | $-1,603.00MM |
| Financing Cash Flow | $-1,235.00MM | $-329.00MM | $-382.00MM |
| Earnings Per Share* | $5.05 | $5.82 | $7.39 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.